• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Delcath Systems Inc (NQ: DCTH )

    11.01 +0.11 (+1.01%)
    Streaming Delayed Price Updated: 9:46 AM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Delcath Systems Inc

    < Previous 1 2 3 4 Next >
    Delcath Systems to Participate in Upcoming Investor Conferences
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems to Host Third Quarter 2024 Earnings Call
    From Delcath Systems, Inc.
    Via Business Wire
    Analyst Scoreboard: 4 Ratings For Delcath Systems
    Via Benzinga
    Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Delcath Systems, Inc.
    Via Business Wire
    Assessing Delcath Systems: Insights From 4 Financial Analysts
    Via Benzinga
    Earnings Preview: Delcath Systems
    Via Benzinga
    Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT™ in Metastatic Uveal Melanoma Subgroups
    From Delcath Systems, Inc.
    Via Business Wire
    'This Is A Very Speculative Situation,' Jim Cramer On ADMA Biologics
    "Mad Money" host Jim Cramer said, "Any time there's immunity-compromised patients, there's some big money down the road." 
    Via Benzinga
    Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Delcath Systems, Inc.
    Via Business Wire
    DCTH Stock Earnings: Delcath Systems Misses EPS, Beats Revenue for Q2 2024
    DCTH stock results show that Delcath Systems missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Delcath Systems Reports Second Quarter 2024 Results and Business Highlights
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems Announces CMS Approval for NTAP for HEPZATO KIT™
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems to Participate in Upcoming Investor Conferences
    From Delcath Systems, Inc.
    Via Business Wire
    Delcath Systems to Host Second Quarter 2024 Earnings Call
    From Delcath Systems, Inc.
    Via Business Wire
    Have $5-10? 7 Affordable Stocks That Are About to Breakout.
    These stocks are already showing gains this year, but they are all still affordable stocks ready to breakout. 
    Via InvestorPlace
    Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath’s Board of Directors
    From Delcath Systems, Inc.
    Via Business Wire
    Wall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday?
    Wall Street is experiencing a subdued trading session, with all major indices showing minimal movement around midday in New York. 
    Via Benzinga
    Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    DCTH Stock Earnings: Delcath Systems Beats EPS, Beats Revenue for Q1 2024
    DCTH stock results show that Delcath Systems beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    DCTH Stock Earnings: Delcath Systems Beats EPS, Misses Revenue for Q4 2023
    DCTH stock results show that Delcath Systems beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    Earnings Scheduled For March 26, 2024
    Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.